Science & Research
Oncotelic's Joint Venture Sapu Nano Receives Approval for Phase 1 Trial of Injectable Everolimus for Breast Cancer
Sapu Nano's approval to begin Phase 1 clinical trials for an injectable version of Everolimus represents a potential breakthrough in breast cancer treatment by enabling full drug absorption compared to the oral version's limited 10% bioavailability.
Rehabilitated Loggerhead Sea Turtle 'Pegasus' Set for Release with Satellite Tracking
The New York Marine Rescue Center's release of a rehabilitated loggerhead sea turtle equipped with a satellite tag provides crucial data for marine conservation and demonstrates successful cross-institutional collaboration in wildlife rehabilitation.
UK Startup Achieves Quantum Computing Breakthrough Using Standard Silicon Chips
A UK startup has developed the first quantum computer using standard silicon chips, potentially democratizing quantum technology by reducing costs and eliminating the need for specialized components.
GeoVax Expands Gedeptin Cancer Therapy Development to Additional Solid Tumor Types
GeoVax Labs is expanding its Gedeptin cancer therapy development to include triple negative breast cancer and cutaneous malignancies, building on checkpoint inhibitor momentum and KEYNOTE-689 results to potentially improve outcomes for broader solid tumor patients.
Stanford's Fatima Rodriguez Receives Prestigious 2025 Joseph A. Vita Award for Cardiovascular Research
Dr. Fatima Rodriguez's recognition with the Joseph A. Vita Award highlights significant advancements in personalized cardiovascular risk prediction and prevention strategies that address health disparities across diverse populations.
Quantumzyme Corp. Secures Patent for Sustainable Ibuprofen Manufacturing Process
Quantumzyme Corp. has achieved a significant milestone with the USPTO publication of its patent for an enzymatic ibuprofen synthesis method, representing a major advancement in sustainable pharmaceutical manufacturing.
Creative Biolabs Launches Advanced Antibody Tools for Neuroscience Research
Creative Biolabs has developed specialized antibody products targeting key neurological proteins that could accelerate research into neurodegenerative diseases, movement disorders, and synaptic function.
New Research Reveals Listening Skills as Critical Factor in Relationship Success
Oliver Drakeford Therapy's study demonstrates that strong listening skills can increase the likelihood of thriving relationships by 43 times, highlighting the transformative power of effective communication in couples therapy.
LabConnect and The Bracken Group Forge Strategic Partnership to Enhance Radiopharmaceutical Trial Support
LabConnect's collaboration with The Bracken Group addresses the growing demand for specialized radiopharmaceutical expertise in clinical trials, positioning the partnership to better serve biotech and pharmaceutical companies developing targeted treatments and diagnostics.
Leading Mental Health Expert to Address Youth Crisis at Biofeedback Conference
Dr. Roseann Capanna-Hodge will present brain-based strategies for addressing the youth mental health crisis at the NRBS 2025 conference, offering practical solutions for clinicians, educators, and parents dealing with rising rates of anxiety and depression.
New York Architect Meshal Alradadi Gains International Recognition for Data-Driven Design Approach
Meshal Alradadi's innovative work merging architecture with information systems represents a significant shift toward data-driven design processes that could transform how buildings are conceptualized and constructed.
Researchers Challenge Biochar's Role in Boosting Biogas Production, Calling for More Rigorous Evidence
Scientists question whether conductive additives like biochar truly enhance biogas production through direct electron transfer, highlighting the need for standardized research to validate claims that could revolutionize renewable energy from organic waste.
Circular DNA Fragments Identified as Key Factor in Glioblastoma Lethality
International researchers have discovered that rogue circular DNA fragments operating independently from chromosomes may explain why glioblastoma remains so deadly despite medical advances, potentially opening new treatment pathways.
A. Aubrey Bodine Archive Offers Glimpse Into Mid-Century Maryland Through 6,000 Photographs
The extensive photographic archive of A. Aubrey Bodine, featuring over 6,000 images documenting mid-20th century Maryland life, provides valuable historical insight and artistic legacy through his pioneering pictorialist approach.
MUSC Professor Daniel Lackland to Receive 2025 Population Research Prize for Hypertension Research
Dr. Daniel Lackland's recognition by the American Heart Association highlights the critical importance of population-level research in addressing cardiovascular health disparities and improving hypertension treatment strategies globally.
GeoVax Reaffirms Commitment to Vaccine Safety Amid Development of GEO-CM04S1 for Immunocompromised Patients
GeoVax Labs emphasizes its evidence-based approach to vaccine safety and the advancement of GEO-CM04S1, a COVID-19 vaccine designed for vulnerable populations with weakened immune systems who respond poorly to current options.
Psychological Distress After Heart Attack Linked to Increased Risk of Future Cardiac Events
New research reveals that psychological distress affects up to 50% of heart attack survivors and increases the risk of future cardiac events by 1.3 to 2 times, highlighting the critical need for integrated mental health care in cardiac recovery.
Alicia Kali Establishes World's First Neuroscience and BioQuantum Engineering Institute to Advance Human Health and AI Performance
Alicia Kali has launched the world's first nonprofit institute dedicated to neuroscience and bioquantum engineering, aiming to unify biological intelligence, regenerative health, and artificial cognition through groundbreaking research.
Soligenix Advances Oral Mucositis Treatment SGX942 with Combined Clinical Data Analysis
Soligenix is leveraging positive phase 2 and 3 clinical data to design a second pivotal trial for SGX942, addressing the critical unmet medical need for oral mucositis treatment in cancer patients.
LaFleur Minerals Reports Promising Sulphide-Rich Mineralized Zone in Swanson Gold Project Drilling
LaFleur Minerals has identified a significant sulphide-rich mineralized zone at least 17.9 meters wide during its Swanson Gold Project drilling program in Quebec's Abitibi Greenstone Belt, indicating potential for substantial gold discovery.
Lantern Pharma Completes Japan Enrollment in Phase 2 Trial for Never-Smoker Lung Cancer Treatment
Lantern Pharma has achieved targeted patient enrollment in Japan for its Phase 2 HARMONIC trial evaluating LP-300 in never-smoker non-small cell lung cancer patients, marking significant progress in addressing an underserved population with high unmet medical need.
UCLA Researchers Awarded $2M Grant for MRI-Guided Cancer Radiation Therapy Study
UCLA Health receives a $2 million grant from ViewRay Systems to advance research on MRI-guided radiation therapy for targeted cancer treatment, highlighting growing investment in precision oncology technologies.
Lexaria's DehydraTECH Shows Enhanced Brain Delivery of Semaglutide in Preclinical Study
Lexaria Bioscience's drug delivery technology demonstrated improved brain distribution of GLP-1 drug semaglutide in rodents, potentially leading to better safety and efficacy for weight loss treatments.
Creative Biolabs Expands IVD Capabilities with Integrated Protein and Nucleic Acid Detection
Creative Biolabs has enhanced its in vitro diagnostics services by integrating protein and nucleic acid detection technologies, offering researchers more comprehensive biomarker analysis for early disease detection and complex condition research.
Creative Biolabs Accelerates CAR-T Therapy Innovation with Advanced Development Platform
Creative Biolabs is enhancing CAR-T therapy research through its comprehensive development platform, offering specialized viral vectors and ready-made plasmids that address critical challenges in scalability, cost, and technical efficiency for both blood cancers and emerging solid tumor applications.
Plus Therapeutics Subsidiary CNSide Diagnostics Achieves CLIA Accreditation for CNS Cancer Testing Lab
CNSide Diagnostics has received CMS accreditation for its clinical laboratory, enabling broader patient access and insurance coverage for its cerebrospinal fluid assay platform used in central nervous system cancer detection.
Dietary Protein Restriction May Enhance Glioblastoma Treatment Efficacy, Study Finds
University of Michigan research indicates that low-protein diets combined with serine-free protein shakes could improve chemotherapy and radiation outcomes for glioblastoma patients by making tumors more vulnerable to treatment.
Streamline Scientific Launches Enhanced PCR Reporting Service to Combat Antibiotic Misuse in UTI Treatment
Streamline Scientific's new PCR reporting service integrates clinical guidelines directly into test results to help physicians make more informed antibiotic prescribing decisions for urinary tract infections, addressing the critical issue of antimicrobial resistance.
GeoVax's CM04S1 Vaccine Shows Promise for Immunocompromised Patients in Phase 2 Trials
GeoVax Labs' next-generation COVID-19 vaccine candidate demonstrates superior immune responses in immunocompromised patients compared to mRNA vaccines, potentially addressing critical gaps in current vaccination strategies.
D-Wave Announces First Quantum Computing User Conference in Japan Amid Surging APAC Demand
D-Wave Quantum is hosting its inaugural Qubits Japan 2025 conference in Tokyo to address the 83% increase in bookings for annealing quantum computing technology across the Asia Pacific region.